RS
Therapeutic Areas
Mondego Bio Pipeline
| Drug | Indication | Phase |
|---|---|---|
| PTPN2 Inhibitor (ZE00-0388 / Clinical Candidate) | Cancer Immunotherapy (specific indications not disclosed) | Pre-clinical |
| Drug | Indication | Phase |
|---|---|---|
| PTPN2 Inhibitor (ZE00-0388 / Clinical Candidate) | Cancer Immunotherapy (specific indications not disclosed) | Pre-clinical |